Molecular and structural architecture of polyQ aggregates in yeast

Huntington’s disease is caused by the expansion of a polyglutamine (polyQ) tract in the N-terminal exon of huntingtin (HttEx1), but the cellular mechanisms leading to neurodegeneration remain poorly understood. Here we present in situ structural studies by cryoelectron tomography of an established y...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 115; no. 15; pp. E3446 - E3453
Main Authors: Gruber, Anselm, Hornburg, Daniel, Antonin, Matthias, Krahmer, Natalie, Collado, Javier, Schaffer, Miroslava, Zubaite, Greta, Lüchtenborg, Christian, Sachsenheimer, Timo, Brügger, Britta, Mann, Matthias, Baumeister, Wolfgang, Hartl, F. Ulrich, Hipp, Mark S., Fernández-Busnadiego, Rubén
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 10-04-2018
Series:PNAS Plus
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Huntington’s disease is caused by the expansion of a polyglutamine (polyQ) tract in the N-terminal exon of huntingtin (HttEx1), but the cellular mechanisms leading to neurodegeneration remain poorly understood. Here we present in situ structural studies by cryoelectron tomography of an established yeast model system of polyQ toxicity. We find that expression of polyQ-expanded HttEx1 results in the formation of unstructured inclusion bodies and in some cases fibrillar aggregates. This contrasts with recent findings in mammalian cells, where polyQ inclusions were exclusively fibrillar. In yeast, polyQ toxicity correlates with alterations in mitochondrial and lipid droplet morphology, which do not arise from physical interactions with inclusions or fibrils. Quantitative proteomic analysis shows that polyQ aggregates sequester numerous cellular proteins and cause a major change in proteome composition, most significantly in proteins related to energy metabolism. Thus, our data point to a multifaceted toxic gain-of-function of polyQ aggregates, driven by sequestration of endogenous proteins and mitochondrial and lipid droplet dysfunction.
Bibliography:Author contributions: A.G., D.H., M.A., B.B., M.M., W.B., F.U.H., M.S.H., and R.F.-B. designed research; A.G., D.H., M.A., N.K., J.C., M.S., G.Z., C.L., and T.S. performed research; B.B., M.S.H., and R.F.-B. supervised the experiments; A.G., D.H., M.A., N.K., C.L., and T.S. analyzed data; and D.H., W.B., F.U.H., M.S.H., and R.F.-B. wrote the paper.
Contributed by Wolfgang Baumeister, February 23, 2018 (sent for review October 16, 2017; reviewed by Jeffery W. Kelly and Sheena E. Radford)
Reviewers: J.W.K., The Scripps Research Institute; and S.E.R., University of Leeds.
1A.G., D.H., and M.A. contributed equally to this work.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1717978115